Andlauer Healthcare Group Inc.
AND.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$1,699,732 | CA$1,714,316 | CA$1,979,846 | CA$2,109,115 |
| - Cash | CA$40,483 | CA$59,740 | CA$65,855 | CA$24,990 |
| + Debt | CA$181,210 | CA$127,900 | CA$163,286 | CA$187,251 |
| Enterprise Value | CA$1,840,459 | CA$1,782,476 | CA$2,077,277 | CA$2,271,376 |
| Revenue | CA$650,477 | CA$647,952 | CA$648,423 | CA$440,115 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Gross Profit | CA$147,204 | CA$147,481 | CA$158,847 | CA$110,754 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| EBITDA | CA$166,717 | CA$166,963 | CA$175,068 | CA$157,375 |
| % Margin | 25.6% | 25.8% | 27% | 35.8% |
| Net Income | CA$64,468 | CA$66,140 | CA$76,275 | CA$89,954 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| % Growth | 1.9% | -13.4% | -20.4% | – |
| Operating Cash Flow | CA$124,402 | CA$104,419 | CA$137,128 | CA$84,091 |
| Capital Expenditures | -CA$20,378 | -CA$25,592 | -CA$27,960 | -CA$9,668 |
| Free Cash Flow | CA$104,024 | CA$78,827 | CA$109,168 | CA$74,423 |